0001144204-19-001103.txt : 20190108
0001144204-19-001103.hdr.sgml : 20190108
20190108163855
ACCESSION NUMBER: 0001144204-19-001103
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190102
FILED AS OF DATE: 20190108
DATE AS OF CHANGE: 20190108
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: THANGARAJ IMMANUEL
CENTRAL INDEX KEY: 0001213308
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-10113
FILM NUMBER: 19516366
MAIL ADDRESS:
STREET 1: 10001 WOODLOCH FOREST DRIVE SUITE 175
CITY: THE WOODLANDS
STATE: TX
ZIP: 77380
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ACURA PHARMACEUTICALS, INC
CENTRAL INDEX KEY: 0000786947
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 110853640
STATE OF INCORPORATION: NY
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 616 N. NORTH COURT, SUITE 120
CITY: PALATINE
STATE: IL
ZIP: 60067
BUSINESS PHONE: 847-705-7709
MAIL ADDRESS:
STREET 1: 616 N. NORTH COURT, SUITE 120
STREET 2: .
CITY: PALATINE
STATE: IL
ZIP: 60067
FORMER COMPANY:
FORMER CONFORMED NAME: HALSEY DRUG CO INC/NEW
DATE OF NAME CHANGE: 19920703
4
1
tv510618_4.xml
OWNERSHIP DOCUMENT
X0306
4
2019-01-02
0
0000786947
ACURA PHARMACEUTICALS, INC
ACUR
0001213308
THANGARAJ IMMANUEL
10001 WOODLOCH FOREST DRIVE SUITE 175
THE WOODLANDS
TX
77380
1
0
0
0
Common Stock
2019-01-02
4
M
0
66666
A
126192
D
Common Stock
1956396
I
By Essex Woodlands Health Venture Fund V, L.P.
Restricted Stock Units (2017 Plan)
2019-01-02
4
M
0
66666
D
Common Stock
66666
0
D
Restricted Stock Units (2017 Plan)
2019-01-02
4
A
0
83333
A
Common Stock
83333
83333
D
Represents exchange of restricted stock units.
Par value of $.01 per share must be paid by Reporting Person upon exchange of Restricted Stock Units for stock
Does not include Restricted Stock Units.
1 - for - 1
25% of Restricted Stock Units vested on March 31, 2018, 25% vested on June 30, 2018; 25% vested on September 30, 2018 and 25% vested on December 31, 2018. Restricted Stock Units are being exchanged on a one for one basis for common stock, in each case upon payment of par value.
N/A
25% of Restricted Stock Units vest on the last day of each of March, June, September and December 2019, subject to immediate vesting in the event of a change of control and certain other events. Reporting Person may elect to exchange up to 40% of Restricted Stock Units for cash and the remaining Restricted Stock Units will be exchanged on a one for one basis for common stock, in each case upon payment of, or deduction of par value. Distributions in respect of vested Restricted Stock Units will be made on the first business day of January 2020, or earlier upon a change of control.
The reporting person is a managing director of the general partner of Essex Woodlands Health Ventures Fund V, L.P. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
/s/ Bruce Wesson
2019-01-08